A UK inquiry finds that around 23,000 deaths in England could have been prevented if the national lockdown had begun a week earlier in March 2020, highlighting major government failings during the pandemic.
Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.
New data explores why some in the UK continue to experience vaccine hesitancy - with one man explaining that "it is human nature to have second thoughts".
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.
The European Commission on Thursday (6 May) responded to a US declaration of support for the TRIPS waiver, stating that they were open to further discussions without explicit agreement.
